Psychosocial HealthPS IVGNCT07650071
PS IVG : Psychosocial Determinants of Late-term Abortions (14-16 Weeks' Gestation) at Avignon Hospital
A study testing Health survey in people with Psychosocial Health and Abortion, run by Centre Hospitalier Henri Duffaut - Avignon at 1 site in France.
Trial summary
Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Psychosocial Health, Abortion
- What is being tested?
- Health survey
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 15 Jun 2026to 15 Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient aged ≥ 18 years
- Pregnancy ≥ 14 weeks' gestation
- Patient attending Avignon Hospital for a surgical abortion
- Willing to participate in the study
Who cannot join
- Medical abortion (non-surgical means of abortion)
- Ectopic pregnancy
- Inability to complete the questionnaire
- Patients under legal protection measures (guardianship, curatorship, or court-ordered protection)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Avignon, 84000
Marilyne Grinand, PhD, (+33)0432759392, grinand.marilyne@ch-avignon.fr
Perrine Mazet, MD
About this study
Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. However, it may also expose them to psychological troubles and difficulties in accessing healthcare. This study aims to identify the psychosocial determinants and disruptions in the primary care pathway associated with late abortions (≥14 weeks' gestation [WG]) in order to propose preventive actions, particularly regarding contraception, screening, and referral, directly applicable in general practice.
- Conditions
- Psychosocial Health, Abortion
- Being tested
- Health survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health surveyBehavioural
It consists of a single anonymous questionnaire, to be completed once only, on a secure online platform, accessed using a QR code provided directly by the healthcare professional.
The questionnaire consists of 39 main questions, predominantly with closed-ended response options. The average completion time is estimated between 10 and 20 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Health survey | Experimental | This is a health survey. Following patient recruitment, the physician will explain the study and its objectives. If the patient agrees to participate, a QR code will be provided to allow anonymous access to the study questionnaire. The patient will be invited to complete the questionnaire after the medical consultation. Receives: Behavioral: Health survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Describe the sociodemographic profile of patients undergoing late-term abortion at Avignon Hospital.
Measured: Inclusion
Secondary outcomes (10)
Proportion of patients who attended the hospital for a late-term abortion following a general practitioner's recommendation.
Measured: Inclusion
Proportion of patients who involved their general practitioner in the care pathway for late-term abortions.
Measured: Inclusion
Descriptive analysis of patients' medical follow-up, medical history and contraceptive practices.
Measured: Inclusion
Frequency of reasons leading to pregnancy and circumstances of pregnancy discovery.
Measured: Inclusion
Descriptive analysis of patients' relationships with their entourage regarding this pregnancy (partner, family, healthcare professionals, etc.).
Measured: Inclusion
Frequency of reasons for choosing abortion.
Measured: Inclusion
Frequency of late-term abortions performed with the support of a general practitioner.
Measured: Inclusion
Frequency of late abortions performed under coercion.
Measured: Inclusion
Frequency of late abortions related to issues in the care pathway.
Measured: Inclusion
Descriptive analysis of patients' difficulties in accessing this type of healthcare.
Measured: Inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jun 2026
- Study start15 Jun 2026 (estimated)
- Primary completion15 Jun 2027 (estimated)
- Study completion15 Sep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Psychosocial HealthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Henri Duffaut - Avignon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Perrine Mazet, MD, Principal investigator, Centre Hospitalier d'Avignon, Service de Gynécologie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07650071
- Sponsor's protocol ID
- PS IVG
- Acronym
- PS IVG
- Status last verified
- Jun 2026
- First submitted
- 10 Jun 2026
- Last updated
- 16 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PS IVG : Psychosocial Determinants of Late-term Abortions (14-16 Weeks' Gestation) at Avignon Hospital
- ClinicalTrials.gov ID
- NCT07650071
- Acronym / sponsor ID
- PS IVG / PS IVG
- Conditions
- Psychosocial Health, Abortion
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Centre Hospitalier Henri Duffaut - AvignonUniversity, hospital or other
- Study start
- 15 Jun 2026 (estimated)
- Primary completion
- 15 Jun 2027 (estimated)
- Study completion
- 15 Sep 2027 (estimated)
- First posted
- 16 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. However, it may also expose them to psychological troubles and difficulties in accessing healthcare. This study aims to identify the psychosocial determinants and disruptions in the primary care pathway associated with late abortions (≥14 weeks' gestation [WG]) in order to propose preventive actions, particularly regarding contraception, screening, and referral, directly applicable in general practice.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Health survey | Experimental | Behavioral: Health surveyThis is a health survey. Following patient recruitment, the physician will explain the study and its objectives. If the patient agrees to participate, a QR code will be provided to allow anonymous access to the study questionnaire. The patient will be invited to complete the questionnaire after the medical consultation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patient aged ≥ 18 years
- Pregnancy ≥ 14 weeks' gestation
- Patient attending Avignon Hospital for a surgical abortion
- Willing to participate in the study
Key exclusion criteria (4 listed)
- Medical abortion (non-surgical means of abortion)
- Ectopic pregnancy
- Inability to complete the questionnaire
- Patients under legal protection measures (guardianship, curatorship, or court-ordered protection)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health surveyIt consists of a single anonymous questionnaire, to be completed once only, on a secure online platform, accessed using a QR code provided directly by the healthcare professional. The questionnaire consists of 39 main questions, predominantly with closed-ended response options. The average completion time is estimated between 10 and 20 minutes. | Behavioural | Health survey |
Primary outcome
Describe the sociodemographic profile of patients undergoing late-term abortion at Avignon Hospital.
Time frame: Inclusion
10 secondary outcomes
Proportion of patients who attended the hospital for a late-term abortion following a general practitioner's recommendation.
Time frame: Inclusion
Proportion of patients who involved their general practitioner in the care pathway for late-term abortions.
Time frame: Inclusion
Descriptive analysis of patients' medical follow-up, medical history and contraceptive practices.
Time frame: Inclusion
Frequency of reasons leading to pregnancy and circumstances of pregnancy discovery.
Time frame: Inclusion
Descriptive analysis of patients' relationships with their entourage regarding this pregnancy (partner, family, healthcare professionals, etc.).
Time frame: Inclusion
Frequency of reasons for choosing abortion.
Time frame: Inclusion
Frequency of late-term abortions performed with the support of a general practitioner.
Time frame: Inclusion
Frequency of late abortions performed under coercion.
Time frame: Inclusion
Frequency of late abortions related to issues in the care pathway.
Time frame: Inclusion
Descriptive analysis of patients' difficulties in accessing this type of healthcare.
Time frame: Inclusion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Psychosocial Health
RecruitingObservational study
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Pediatric Cancer
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Enrolling by invitationObservational study
Long-term Impacts of Psychosocial Stimulation and Iron Supplementation
Iron Deficiency Anemia, Parenting Intervention
Recruiting
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Schizophrenia, Schizo Affective Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Perrine Mazet, MD principal investigator
Centre Hospitalier d'Avignon, Service de Gynécologie
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Health survey in people with Psychosocial Health and Abortion, run by Centre Hospitalier Henri Duffaut - Avignon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marilyne Grinand, PhD ((+33)432759392, grinand.marilyne@ch-avignon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Describe the sociodemographic profile of patients undergoing late-term abortion at Avignon Hospital. (time frame: Inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.